Lopinavir 100mg and Ritonavir 25mg Tablets Manufacturer, Supplier & Exporter in India

Taj Pharma is a leading Lopinavir 100mg and Ritonavir 25mg Tablets manufacturer in India, known for its uncompromising commitment to quality, affordability, and global accessibility. With a state-of-the-art manufacturing facility in Vapi, Gujarat, Taj Pharma has become a trusted exporter and supplier of Lopinavir and Ritonavir Tablets (Kyzilitaj) across Africa, Middle East, Latin America (LATAM), CIS countries, and PAN India. Our formulation combines two highly effective protease inhibitors – Lopinavir and Ritonavir – designed for the management of HIV (Human Immunodeficiency Virus) infection, ensuring patients receive the most reliable treatment.


What are Lopinavir and Ritonavir Tablets (Kyzilitaj)?

Lopinavir 100mg and Ritonavir 25mg Tablets is a fixed-dose combination antiretroviral medicine used in the treatment of HIV infection.

  • Lopinavir (100mg): A potent protease inhibitor that prevents HIV from replicating.
  • Ritonavir (25mg): Enhances the concentration of Lopinavir by inhibiting its metabolism, making it more effective.

Together, these two drugs reduce the viral load in the blood, increase CD4 cell counts, and improve immune function, ultimately slowing down the progression of HIV.

💊 Brand Name by Taj Pharma: Kyzilitaj


Therapeutic Uses of Lopinavir and Ritonavir Tablets

✔️ Treatment of HIV-1 infection in adults and children (as part of combination antiretroviral therapy).
✔️ Reduces viral replication and helps achieve viral suppression.
✔️ Improves immune response and reduces the risk of opportunistic infections.
✔️ Slows disease progression and enhances quality of life for patients.


Mechanism of Action

  • Lopinavir works by inhibiting the HIV protease enzyme, preventing the virus from producing functional proteins required for replication.
  • Ritonavir acts as a pharmacokinetic booster, increasing the plasma concentration of lopinavir by inhibiting the cytochrome P450-3A enzyme.

This synergistic action ensures maximum efficacy of the treatment with optimized dosing.


Dosage & Administration

The recommended adult dose of Lopinavir 100mg + Ritonavir 25mg Tablets is:

  • Two tablets twice daily, administered orally with or without food.
  • For pediatric use, dosage must be calculated based on body weight and medical advice.

📌 Important: Treatment must always be combined with other antiretroviral agents as prescribed by healthcare professionals.


Side Effects of Lopinavir and Ritonavir Tablets

While generally well tolerated, some patients may experience side effects such as:

  • Nausea, vomiting, diarrhea, abdominal pain
  • Headache, dizziness, fatigue
  • Rash or skin reactions
  • Liver enzyme abnormalities
  • Lipodystrophy and changes in cholesterol or triglyceride levels

⚠️ Severe Reactions (Rare but Serious):

  • Severe skin reactions (blistering, peeling)
  • Liver toxicity (jaundice, dark urine, abdominal pain)
  • Allergic reactions (swelling, difficulty breathing)

Precautions & Warnings

✔️ Patients with liver disease should be closely monitored.
✔️ Avoid concurrent use with drugs highly dependent on CYP3A metabolism.
✔️ Inform the physician if pregnant, planning pregnancy, or breastfeeding.
✔️ Regular liver function tests are recommended during therapy.


Why Choose Taj Pharma for Lopinavir and Ritonavir Tablets?

Taj Pharma stands out as the 1 trusted manufacturer of Lopinavir 100mg and Ritonavir 25mg Tablets in India because of:

  • ✅ WHO-GMP and ISO certified facilities in Vapi, Gujarat.
  • ✅ Strict adherence to USFDA, MHRA, and international quality standards.
  • ✅ Affordable pricing for global buyers while ensuring uncompromised quality.
  • ✅ Robust export network across Africa, Middle East, LATAM, and CIS countries.
  • ✅ Expertise in handling large-scale bulk supply and PCD Pharma Franchise opportunities.
  • ✅ Customized packaging and private labeling support for international partners.

Lopinavir and Ritonavir Tablets by Taj Pharma – Key Highlights

🔹 Product Name: Lopinavir 100mg + Ritonavir 25mg Tablets (Kyzilitaj)
🔹 Manufacturer & Exporter: Taj Pharma India, Vapi – Gujarat
🔹 Therapeutic Category: Antiretroviral / Anti-HIV
🔹 Dosage Form: Oral Tablets
🔹 Packaging: Blister / Strip / Bottle (as per client requirement)
🔹 Supply Markets: PAN India, Africa, Middle East, LATAM, CIS, South East Asia


Global Export & Supply

Taj Pharma is recognized globally as a premium supplier and exporter of Lopinavir and Ritonavir Tablets.

🌍 Export Destinations Include:

  • Africa: Nigeria, Kenya, South Africa, Uganda, Tanzania
  • Middle East: UAE, Saudi Arabia, Oman, Kuwait
  • Latin America: Brazil, Mexico, Argentina, Chile
  • CIS & Asia: Russia, Ukraine, Philippines, Vietnam

We provide regulatory and dossier support (CTD, ACTD) to ensure smooth market entry for our partners.


PCD Pharma Franchise for Lopinavir and Ritonavir Tablets

Taj Pharma also offers PCD Pharma Franchise opportunities for Lopinavir and Ritonavir Tablets across PAN India.

Benefits for franchise partners:

  • Monopoly-based distribution rights
  • Marketing and promotional support
  • High profit margins and competitive pricing
  • Reliable and timely delivery

Why Global Buyers Prefer Taj Pharma?

✔️ Over two decades of trust and excellence in pharmaceutical manufacturing.
✔️ Extensive product portfolio covering antiretrovirals, antivirals, antibiotics, oncology medicines, and more.
✔️ Strong reputation as a leading HIV medicine supplier in India.
✔️ Proven expertise in catering to tenders, institutional supply, and government procurement worldwide.


Taj Pharma has established itself as a leading manufacturer, supplier, and exporter of Lopinavir 100mg and Ritonavir 25mg Tablets (Kyzilitaj) in India. With world-class manufacturing standards, extensive global reach, and commitment to affordable healthcare, we continue to empower healthcare providers and patients in the fight against HIV/AIDS. If you are looking for a trusted pharmaceutical partner for Lopinavir and Ritonavir Tablets, Taj Pharma is the name you can rely on.